PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 112 filers reported holding PROVENTION BIO INC in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $265 | +93.4% | 11,000 | -15.4% | 0.01% | +62.5% |
| Q4 2022 | $137 | -99.8% | 13,000 | 0.0% | 0.01% | +166.7% |
| Q3 2022 | $59,000 | +13.5% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $52,000 | -45.3% | 13,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $95,000 | +30.1% | 13,000 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $73,000 | +4.3% | 13,000 | +18.2% | 0.00% | 0.0% |
| Q3 2021 | $70,000 | -24.7% | 11,000 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $93,000 | -19.1% | 11,000 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $115,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS LLC | 116,324 | $2,803,407 | 0.00% |